Stay updated on ABBV-105/Upadacitinib Combo Follow-Up Clinical Trial

Sign up to get notified when there's something new on the ABBV-105/Upadacitinib Combo Follow-Up Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABBV-105/Upadacitinib Combo Follow-Up Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 from the site records.
    Difference
    0.0%
    Check dated 2026-03-19T04:56:58.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    - Revision badge updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-12T03:08:18.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    49 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the prior funding/operating-status notice (Revision: v3.4.1).
    Difference
    0.3%
    Check dated 2026-02-11T16:39:44.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Added a government funding/status notice about the NIH Clinical Center and operations. Updated the site version from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T10:48:45.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Added a glossary toggle and new labels (Last Update Submitted that Met QC Criteria; Revision: v3.4.0) while removing older labels with different capitalization/wording (Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4).
    Difference
    0.1%
    Check dated 2026-01-28T06:26:35.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The revision line has been updated to v3.3.4, replacing the previous v3.3.3.
    Difference
    0.0%
    Check dated 2026-01-14T02:43:41.000Z thumbnail image

Stay in the know with updates to ABBV-105/Upadacitinib Combo Follow-Up Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABBV-105/Upadacitinib Combo Follow-Up Clinical Trial page.